BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15963781)

  • 1. NOD2 and Crohn's disease: loss or gain of function?
    Eckmann L; Karin M
    Immunity; 2005 Jun; 22(6):661-7. PubMed ID: 15963781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
    Buhner S; Buning C; Genschel J; Kling K; Herrmann D; Dignass A; Kuechler I; Krueger S; Schmidt HH; Lochs H
    Gut; 2006 Mar; 55(3):342-7. PubMed ID: 16000642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
    Wehkamp J; Stange EF
    Trends Mol Med; 2005 Jul; 11(7):307-9. PubMed ID: 15955743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders.
    Kambe N; Nishikomori R; Kanazawa N
    J Dermatol Sci; 2005 Aug; 39(2):71-80. PubMed ID: 15927452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
    Barreiro-de Acosta M; Peña AS
    Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD15/NOD2 mutations in Crohn's disease.
    Hugot JP
    Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis.
    Stockton JC; Howson JM; Awomoyi AA; McAdam KP; Blackwell JM; Newport MJ
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):157-60. PubMed ID: 15145460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population.
    Nagy Z; Karádi O; Rumi G; Rumi G; Pár A; Mózsik G; Czirják L; Süto G
    Ann N Y Acad Sci; 2005 Jun; 1051():45-51. PubMed ID: 16126943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 in Crohn's disease--loss or gain of function mutations?
    Zelinkova Z; Stokkers P; Hommes DW
    Neth J Med; 2005 Sep; 63(8):286-7. PubMed ID: 16186636
    [No Abstract]   [Full Text] [Related]  

  • 10. Signalling pathways and molecular interactions of NOD1 and NOD2.
    Strober W; Murray PJ; Kitani A; Watanabe T
    Nat Rev Immunol; 2006 Jan; 6(1):9-20. PubMed ID: 16493424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
    Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
    J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
    Philpott DJ; Viala J
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2/CARD15 polymorphism R702W.
    van Steensel MA; Badeloe S; Winnepenninckx V; Vreeburg M; Steijlen PM; van Geel M
    Exp Dermatol; 2008 Dec; 17(12):1057-8. PubMed ID: 18616576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does smoking influence the course of Crohn's disease in patients with the presence of gene NOD2/CARD15 mutation?].
    Dobrowolska-Zachwieja A; Kaczmarek M; Hoppe-Gołebiewska J; Kalak R; Słomski R; Linke K
    Pol Merkur Lekarski; 2005 May; 18(107):560-5. PubMed ID: 16161956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.
    Watanabe T; Kitani A; Strober W
    Gut; 2005 Nov; 54(11):1515-8. PubMed ID: 16227353
    [No Abstract]   [Full Text] [Related]  

  • 18. Colonic lymphoid follicles and NOD2/CARD15 mutational status in Crohn's disease.
    Nascimbeni R; Villanacci V; Bassotti G; Fisogni S; Gervasi M; Rossi E; Di Lorenzo D
    Br J Surg; 2009 Jun; 96(6):655-62. PubMed ID: 19434699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NODs: intracellular proteins involved in inflammation and apoptosis.
    Inohara N; Nuñez G
    Nat Rev Immunol; 2003 May; 3(5):371-82. PubMed ID: 12766759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?
    Rogler G; Holler E
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):62-3. PubMed ID: 16265048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.